A carregar...
A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study
OBJECTIVE: We aimed at comparing clinical/immunological outcomes in human immunodeficiency virus (HIV)-infected patients who were treated with CYP2B6-guided and conventional efavirenz (EFV) therapy. METHODS: This study was a 24-week prospective randomized controlled trial. Eligible patients were HIV...
Na minha lista:
| Publicado no: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4638311/ https://ncbi.nlm.nih.gov/pubmed/26622191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S86446 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|